Calamos Advisors
GH icon

Calamos Advisors’s Guardant Health GH Stock Holding History

Calamos Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.68M Sell
50,668
-5,800
-10% -$582K 0.02% 570
2025
Q4 		$5.77M Buy
56,468
+11,968
+27% +$1.07M 0.02% 505
2025
Q3 		$2.78M Buy
+44,500
New +$2.42M 0.01% 603

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Calamos Advisors's GH Position: Q1 2026 in Review

Calamos Advisors reduced its Guardant Health (GH) stake by 10% in Q1 2026, selling an estimated $582K and leaving 50,668 shares worth $4.68M. The position accounts for 0.02% of the portfolio, ranked #570.

Calamos Advisors first reported a position in GH in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.77M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Calamos Advisors held 50,668 shares of Guardant Health worth $4.68M as of Q1 2026.
  • Calamos Advisors sold 5,800 Guardant Health shares in Q1 2026, an estimated $582K.
  • Guardant Health made up 0.02% of Calamos Advisors's portfolio in Q1 2026, its #570 holding.
  • Calamos Advisors first reported a position in Guardant Health in Q3 2025 and has held it in 3 quarters since.
  • Calamos Advisors's Guardant Health position peaked at $5.77M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.